These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 23851909)
1. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug. Brown DL; Lalla CD; Masselink AJ Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909 [TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion. Waineo MF; Kuhn TC; Brown DL J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426 [TBL] [Abstract][Full Text] [Related]
3. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia. Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370 [TBL] [Abstract][Full Text] [Related]
4. Vancomycin dosing in children and young adults: back to the drawing board. Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205 [TBL] [Abstract][Full Text] [Related]
5. Correlation of the vancomycin 24-h area under the concentration-time curve (AUC Issaranggoon Na Ayuthaya S; Katip W; Oberdorfer P; Lucksiri A Int J Infect Dis; 2020 Mar; 92():151-159. PubMed ID: 31935538 [TBL] [Abstract][Full Text] [Related]
6. Optimizing Vancomycin Use Through 2-Point AUC-Based Therapeutic Drug Monitoring in Pediatric Patients. Suchartlikitwong P; Anugulruengkitt S; Wacharachaisurapol N; Jantarabenjakul W; Sophonphan J; Theerawit T; Chatsuwan T; Wattanavijitkul T; Puthanakit T J Clin Pharmacol; 2019 Dec; 59(12):1597-1605. PubMed ID: 31342543 [TBL] [Abstract][Full Text] [Related]
7. Vancomycin dosing in children: what is the question? Cole TS; Riordan A Arch Dis Child; 2013 Dec; 98(12):994-7. PubMed ID: 23956256 [TBL] [Abstract][Full Text] [Related]
10. Vancomycin dosing and target attainment in children. Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708 [TBL] [Abstract][Full Text] [Related]
11. Association of Vancomycin AUC/MIC and Trough Concentration With Early Clinical Response in Enterococcus or Coagulase-Negative Staphylococcus Infection: A Prospective Study. Pitayakittiwong C; Sermsappasuk P; Meesing A; Jaisue S J Clin Pharmacol; 2024 Aug; 64(8):1006-1014. PubMed ID: 38639115 [TBL] [Abstract][Full Text] [Related]
12. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Eiland LS; English TM; Eiland EH Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865 [TBL] [Abstract][Full Text] [Related]
13. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575 [TBL] [Abstract][Full Text] [Related]
14. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients. Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639 [TBL] [Abstract][Full Text] [Related]
15. Improved vancomycin dosing in children using area under the curve exposure. Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565 [TBL] [Abstract][Full Text] [Related]
16. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates. Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667 [TBL] [Abstract][Full Text] [Related]
17. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients. Ploessl C; White C; Manasco K Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203 [TBL] [Abstract][Full Text] [Related]
18. Innovative approaches to optimizing the delivery of vancomycin in individual patients. Pai MP; Neely M; Rodvold KA; Lodise TP Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/pharmacodynamic analysis of vancomycin in patients with Tochikura N; Matsumoto C; Iwabuchi S; Aso H; Fukushima S; Ootsuka S; Ooba N; Ishihara M; Nakajima H; Umemura H; Nakayama T Eur J Hosp Pharm; 2024 Aug; 31(5):440-446. PubMed ID: 36868850 [TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations. Thomson AH; Staatz CE; Tobin CM; Gall M; Lovering AM J Antimicrob Chemother; 2009 May; 63(5):1050-7. PubMed ID: 19299472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]